Leaderboards/Histiocytic Disorders and Treatments

Histiocytic Disorders and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Paul G. Kemps
Leiden University Medical Center
2
Maria Sirenko
Center for Human Genetics
3
Nicola Alesi
Brigham and Women's Hospital
4
Fabian Giehler
Helmholtz Zentrum München
5
Davide Maestri
The Wistar Institute
6
Mingkun Zhan
Fujian Medical University
7
Eily Cournoyer
Cincinnati Children's Hospital Medical Center
8
Yueying Jiang
Sichuan University
9
Sofía Garcés
The University of Texas MD Anderson Cancer Center
10
Mizuna Otsuka
Nagasaki University

Papers

1
Publication in Blood (2024) [49 citations, W4396515124]
Blood|2024
49 cit.
2
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
Nature Communications|2024
45 cit.
3
Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms
Histopathology|2024
17 cit.
4
Publication in Cell stem cell (2025) [17 citations, W4410597204]
Cell stem cell|2025
17 cit.
5
Recurrent <i>CLTC</i>::<i>SYK</i> fusions and <i>CSF1R</i> mutations in juvenile xanthogranuloma of soft tissue
Blood|2024
14 cit.
6
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
Blood Neoplasia|2024
12 cit.
7
Recurrent <i>ETV3</i>::<i>NCOA2</i> fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Blood Advances|2024
11 cit.
8
Sitosterolemia with Orbital Xanthogranulomas
New England Journal of Medicine|2024
5 cit.
9
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis
Blood Cancer Journal|2026
1 cit.
10
Publication in Blood (2025) [W4417016694]
Blood|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Yan Tang
Brigham and Women's Hospital
2
Alan H. Shih
Tisch Hospital
3
Cécile Pagès
Université Toulouse III - Paul Sabatier
4
Karen L. Rech
Mayo Clinic in Arizona
5
Angela Weatherall
Boca Raton Regional Hospital
6
Caroline Hutter
St Anna Children's Hospital
7
Sarah E. Umetsu
University of California, San Francisco
8
Hatem Abou–Ouf
University of Calgary
9
Christine A. Pratilas
Johns Hopkins University
10
Yunjie Li
The Affiliated Yongchuan Hospital of Chongqing Medical University

Papers

1
Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment
Nature Communications|2022
61 cit.
2
How I Diagnose Rosai-Dorfman Disease
American Journal of Clinical Pathology|2023
44 cit.
3
Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
Oncogene|2022
41 cit.
4
An MDM2 degrader for treatment of acute leukemias
Leukemia|2022
32 cit.
5
Uterine Inflammatory Myofibroblastic Tumors
The American Journal of Surgical Pathology|2022
32 cit.
6
Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells
Modern Pathology|2023
31 cit.
7
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
Science Advances|2023
27 cit.
8
Focal nodular hyperplasia–like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation
Human Pathology|2023
17 cit.
9
Clinical outcomes of patients with CIC-rearranged sarcoma: a single institution retrospective analysis
Journal of Cancer Research and Clinical Oncology|2024
12 cit.
10
Preventing Metastasis Using Gold Nanorod-Assisted Plasmonic Photothermal Therapy in Xenograft Mice
Bioconjugate Chemistry|2022
11 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Don Ganem
Novartis (Switzerland)
2
Feng Shao
Nantong University
3
Nancy Raab‐Traub
University of North Carolina at Chapel Hill
4
Julien Haroche
Inserm
5
Kenneth Nilsson
Uppsala University
6
Christopher D.�M. Fletcher
Brigham and Women's Hospital
7
Lawrence M. Weiss
NeoGenomics (United States)
8
Jean Donadieu
Sorbonne Université
9
Jean‐François Emile
Inserm
10
Omar Abdel‐Wahab
Memorial Sloan Kettering Cancer Center

Papers

1
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Nature|2015
6.5k cit.
2
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Nature|2017
3.2k cit.
3
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
4
Pore-forming activity and structural autoinhibition of the gasdermin family
Nature|2016
2.8k cit.
5
Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)
International Journal of Cancer|1976
2.4k cit.
6
Inflammatory caspases are innate immune receptors for intracellular LPS
Nature|2014
2.2k cit.
7
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells
Science|2020
1.3k cit.
8
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus
Nature|2011
1.3k cit.
9
Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases
Modern Pathology|2000
1k cit.
10
Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture
Nature Medicine|1996
1k cit.

Reagents for Histiocytic Disorders and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

DDX5 (D15E10) Rabbit Monoclonal Antibody

#9877$159,381
View Evidence →
Cell Signaling TechnologyEvidence 65

IkappaB alpha (L35A5) Mouse Monoclonal Antibody (Amino-terminal Antigen) (BSA and Azide Free)

#15595$865
View Evidence →
Cell Signaling Technology

mTOR Substrates Antibody Sampler Kit

#9862$509
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

FXR2 (D85D6) Rabbit Monoclonal Antibody

Cited in 5 papers
#7098$161,351
View Evidence →
Cell Signaling Technology

FYVE-CENT Antibody

Cited in 5 papers
#8532$317
View Evidence →
Cell Signaling TechnologyEvidence 66

SLAMF3/CD229 (E5E8A) Rabbit Monoclonal Antibody

#62759$175,376
View Evidence →